156 related articles for article (PubMed ID: 29878018)
21. Bladder cancer diagnosis from bladder wash by Fourier transform infrared spectroscopy as a novel test for tumor recurrence.
Gok S; Aydin OZ; Sural YS; Zorlu F; Bayol U; Severcan F
J Biophotonics; 2016 Sep; 9(9):967-75. PubMed ID: 27041149
[TBL] [Abstract][Full Text] [Related]
22. Fourier-transform infrared spectroscopy discriminates a spectral signature of endometriosis independent of inter-individual variation.
Cheung KT; Trevisan J; Kelly JG; Ashton KM; Stringfellow HF; Taylor SE; Singh MN; Martin-Hirsch PL; Martin FL
Analyst; 2011 May; 136(10):2047-55. PubMed ID: 21423930
[TBL] [Abstract][Full Text] [Related]
23. Clinical chemistry without reagents? An infrared spectroscopic technique for determination of clinically relevant constituents of body fluids.
Hoşafçi G; Klein O; Oremek G; Mäntele W
Anal Bioanal Chem; 2007 Mar; 387(5):1815-22. PubMed ID: 17089104
[TBL] [Abstract][Full Text] [Related]
24. Microsatellite instability analysis for the screening of synchronous endometrial and ovarian cancer in Lynch syndrome.
Bats AS; Roussel H; Narjoz C; Le Frere-Belda MA; Chamming's F; Blons H; Laurent-Puig P; Lecuru F
Anticancer Res; 2013 Sep; 33(9):3977-81. PubMed ID: 24023337
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of ovarian tumour tissues by SR-FTIR spectroscopy: A pilot study.
Grzelak MM; Wróbel PM; Lankosz M; Stęgowski Z; Chmura Ł; Adamek D; Hesse B; Castillo-Michel H
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Oct; 203():48-55. PubMed ID: 29859492
[TBL] [Abstract][Full Text] [Related]
26. The ability of ultrasound to detect gynaecological neoplasms and their ultrasound morphological features.
Tan PL; Willatt JM; Lindsell D
Australas Radiol; 2007 Jun; 51(3):260-6. PubMed ID: 17504319
[TBL] [Abstract][Full Text] [Related]
27. Spectral classification for diagnosis involving numerous pathologies in a complex clinical setting: A neuro-oncology example.
Bury D; Morais CLM; Paraskevaidi M; Ashton KM; Dawson TP; Martin FL
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jan; 206():89-96. PubMed ID: 30086451
[TBL] [Abstract][Full Text] [Related]
28. Using Fourier transform infrared spectroscopy to evaluate biological effects induced by photodynamic therapy.
Lima CA; Goulart VP; Correa L; Zezell DM
Lasers Surg Med; 2016 Jul; 48(5):538-45. PubMed ID: 26899946
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of urine HE4 in patients with ovarian cancer: a meta-analysis.
Jia MM; Deng J; Cheng XL; Yan Z; Li QC; Xing YY; Fan DM; Tian XY
Oncotarget; 2017 Feb; 8(6):9660-9671. PubMed ID: 28039447
[TBL] [Abstract][Full Text] [Related]
30. Characterization of ovarian cancer cells and tissues by Fourier transform infrared spectroscopy.
Li L; Bi X; Sun H; Liu S; Yu M; Zhang Y; Weng S; Yang L; Bao Y; Wu J; Xu Y; Shen K
J Ovarian Res; 2018 Aug; 11(1):64. PubMed ID: 30071867
[TBL] [Abstract][Full Text] [Related]
31. Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications.
Casey MJ; Bewtra C; Lynch HT; Snyder CL; Stacey M
Int J Gynecol Cancer; 2015 May; 25(4):650-6. PubMed ID: 25756400
[TBL] [Abstract][Full Text] [Related]
32. Effects of the Hydration State on the Mid-Infrared Spectra of Urea and Creatinine in Relation to Urine Analyses.
Oliver KV; Maréchal A; Rich PR
Appl Spectrosc; 2016 Jun; 70(6):983-94. PubMed ID: 27170705
[TBL] [Abstract][Full Text] [Related]
33. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
van den Helder R; Wever BMM; van Trommel NE; van Splunter AP; Mom CH; Kasius JC; Bleeker MCG; Steenbergen RDM
Clin Epigenetics; 2020 Nov; 12(1):165. PubMed ID: 33143739
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of endosonography scoring systems in the detection of ovarian and endometrial carcinoma.
Djurdjevic S; Stojanovic S; Kopitovic V; Hadnadjev D; Basta-Nikolic M
J BUON; 2009; 14(1):97-102. PubMed ID: 19373954
[TBL] [Abstract][Full Text] [Related]
35. A gene expression profile test for the differential diagnosis of ovarian versus endometrial cancers.
Lal A; Panos R; Marjanovic M; Walker M; Fuentes E; Kapp DS; Henner WD; Buturovic LJ; Halks-Miller M
Oncotarget; 2012 Feb; 3(2):212-23. PubMed ID: 22371431
[TBL] [Abstract][Full Text] [Related]
36. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.
Vuento MH; Stenman UH; Pirhonen JP; Mäkinen JI; Laippala PJ; Salmi TA
Gynecol Oncol; 1997 Jan; 64(1):141-6. PubMed ID: 8995563
[TBL] [Abstract][Full Text] [Related]
37. MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors.
Cymbaluk-Ploska A; Chudecka-Glaz A; Surowiec A; Pius-Sadowska E; Machalinski B; Menkiszak J
Asian Pac J Cancer Prev; 2016; 17(5):2597-603. PubMed ID: 27268637
[TBL] [Abstract][Full Text] [Related]
38. Label Free Detection of Sensitive Mid-Infrared Biomarkers of Glomerulonephritis in Urine Using Fourier Transform Infrared Spectroscopy.
Yu MC; Rich P; Foreman L; Smith J; Yu MS; Tanna A; Dibbur V; Unwin R; Tam FWK
Sci Rep; 2017 Jul; 7(1):4601. PubMed ID: 28676642
[TBL] [Abstract][Full Text] [Related]
39. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers.
Slupsky CM; Steed H; Wells TH; Dabbs K; Schepansky A; Capstick V; Faught W; Sawyer MB
Clin Cancer Res; 2010 Dec; 16(23):5835-41. PubMed ID: 20956617
[TBL] [Abstract][Full Text] [Related]
40. Raman spectroscopic techniques to detect ovarian cancer biomarkers in blood plasma.
Paraskevaidi M; Ashton KM; Stringfellow HF; Wood NJ; Keating PJ; Rowbottom AW; Martin-Hirsch PL; Martin FL
Talanta; 2018 Nov; 189():281-288. PubMed ID: 30086919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
